Cencora Inc COR

Morningstar Rating

Cencora Exits Fiscal 2026 on Solid Ground, Looks to Specialty Assets for Long-Term Growth

Business Strategy and Outlook

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $300 billion in annual US healthcare distribution sales, Cencora accounts for about a third of the domestic drug distribution market. Its two close competitors are Cardinal Health and McKesson, and the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the US market.

Sponsor Center